Wesco International has been named #24 on Fortune Magazine's 2026 AIQ 75 list, which ranks the top 75 Fortune 500 companies for their AI maturity and ability to deploy AI at scale. This recognition highlights Wesco's strategic focus on AI as a driver of growth, productivity, and customer value, supported by strong governance and innovation. The company plans to continue advancing its AI initiatives to improve customer service, empower employees, and sustain business performance in a digital world.
Wesco International's recognition on Fortune's 2026 AIQ75 list coincides with a mixed performance in the Industrials sector on Pluang. For readers following this sector, here is Pluang's market snapshot as of Sep 30, 2026 03:11 WIB: Of 93 priced Industrials-sector US stocks, 45 rose and 48 fell. Notable movers include Plug Power Inc (PLUG) at USD 1.88 with a 3% Sell / 97% Buy order activity, Modine Manufacturing Company (MOD) at USD 183.83 with 0% Sell / 100% Buy, and Redwire Corporation (RDW) at USD 10.70 with 11% Sell / 89% Buy.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
